Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-09 6:19 pm Sale | 2026-01-08 | 13G | FORTE BIOSCIENCES INC FBRX | Oliveira Steven Michael | 300,100 2.400% | -132,176 (-30.58%) | Filing History |
| 2025-10-10 4:41 pm Sale | 2025-10-01 | 13G | ATHIRA PHARMA INC ATHA | Oliveira Steven Michael | 161,218 4.088% | -38,247 (-19.17%) | Filing History |
| 2025-04-16 4:22 pm Purchase | 2025-04-14 | 13G | ATHIRA PHARMA INC ATHA | Oliveira Steven Michael | 199,465 5.109% | 199,465 (New Position) | Filing History |
| 2025-01-10 8:13 pm Purchase | 2024-11-20 | 13G | FORTE BIOSCIENCES INC FBRX | Oliveira Steven Michael | 432,276 6.760% | 432,276 (New Position) | Filing History |
| 2024-04-29 11:44 am Purchase | 2024-04-22 | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 791,235 8.890% | 693,032 (+705.71%) | Filing History |
| 2023-08-18 10:50 am Sale | 2023-08-08 | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 98,203 3.890% | -24,395 (-19.90%) | Filing History |
| 2022-10-07 12:46 pm Purchase | 2022-09-14 | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 122,598 8.080% | 83,297 (+211.95%) | Filing History |
| 2022-05-09 4:29 pm Sale | 2022-05-02 | 13G | PEAK BIO INC WT EXP 11/1/2027 PKBOW | Oliveira Steven Michael | 0 0.000% | -400,000 (Position Closed) | Filing History |
| 2022-03-09 11:18 am Purchase | 2022-03-07 | 13G | TREVI THERAPEUTICS INC TRVI | Oliveira Steven Michael | 1,340,000 5.180% | 1,340,000 (New Position) | Filing History |
| 2022-03-02 5:24 pm Sale | 2022-02-23 | 13G | 4D PHARMA PLC SPONSORED ADS LBPS | Oliveira Steven Michael | 8,913,432 4.940% | -1,305,000 (-12.77%) | Filing History |
| 2022-02-03 10:39 am Sale | 2022-02-02 | 13G | 4D PHARMA PLC SPONSORED ADS LBPS | Oliveira Steven Michael | 10,218,432 5.670% | -10,664,994 (-51.07%) | Filing History |
| 2022-01-19 3:20 pm Sale | 2022-01-18 | 13G | RENOVACOR INC RCOR | Oliveira Steven Michael | 575,000 3.330% | -325,000 (-36.11%) | Filing History |
| 2021-09-21 1:31 pm Sale | 2021-09-07 | 13G | FORTE BIOSCIENCES FBRX | Oliveira Steven Michael | 0 0.000% | -26,043 (Position Closed) | Filing History |
| 2021-04-14 5:17 pm Purchase | 2021-04-12 | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 39,301 13.870% | 16,061 (+69.11%) | Filing History |
| 2021-04-12 06:09 am Purchase | 2021-03-22 | 13G | 4D PHARMA PLC SPONSORED ADS LBPS | Oliveira Steven Michael | 20,883,426 11.670% | 20,883,426 (New Position) | Filing History |